Identification of a potentially radiosensitive subgroup among patients with breast cancer

Journal of the National Cancer Institute

Volumn 86, Issue 21, 1994, Pages 1627-1634

  Lavin, Martin F ^a   Bennett, Ian ^b   Ramsay, Jonathan ^c   Gardiner, Robert A ^b   Seymour, Greg J ^b   Farrell, Aine ^a   Walsh, Michael ^b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Queensland Radium Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATAXIA TELANGIECTASIA; BLADDER CANCER; BREAST CANCER; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; GAMMA IRRADIATION; HETEROZYGOTE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; LYMPHOBLASTOID CELL; MAJOR CLINICAL STUDY; MITOSIS INHIBITION; RADIOSENSITIVITY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ATAXIA TELANGIECTASIA; BREAST NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; FEMALE; FLOW CYTOMETRY; G2 PHASE; GAMMA RAYS; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0028090549     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/86.21.1627     Document Type: Article

References (28)

1. McMichael AJ, Armstrong BK: Breast cancer in Australia: occurrence, risk factors, preven- tability and screening. Med J Aust 148:86-88, 1988
2. Schwab L: Breast cancer challenge sounded at Capitol. J Natl Cancer Inst 83:914, 1991
3. Feuer EJ, Wun LM, Boring CC, et al: The lifetime risk of developing breast cancer fsee comment citations in Medline]. J Natl Cancer Inst 85:892-897, 1993
4. Logan WP: Cancer of the breast: no decline in mortality. WHO Chronicle 29:262-278, 1975
5. Shapiro S: More on screening and breast cancer incidence [editorial]. J Natl Cancer Inst 83:1522-1523, 1991
6. Lantz PM, Remington PL, Newcomb PA: Mammography screening and increased incidence of breast cancer. Am J Public Health 81:462-465, 1991
7. Tabar L, Fagerberg CJ, Gad A, et al: Reduction of mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Working Group of the Swedish National Board of Health and Welfare. Lancet 1:829-832, 1985
8. Cassileth BR: Breast cancer surveillance: on increasing its effectiveness while reducing its negative psychological effects [editorial; see comment citations in Medline]. J Natl Cancer Inst 84:2-3, 1992
9. Swift M, Morrell D, Massey RB, et al: Incidence of cancer in 161 families affected byataxia-telangiectasia [see comment citations in Medline], N Engl J Med 325:1831-1836, 1991
10. Boder E: Ataxia-telangiectasia: an overview. In Ataxia-Telangiectasia, Genetics, Neuropathology and Immunology of a Degenerative Disease of Childhood (Gatti RA, Swift M, eds). New York: Alan R Liss, 1985, pp 1-63
11. Pippard EC, Hall AJ, Barker DJ, et al: Cancer in homozygotes and heterozygotes of ataxia- telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 48:2929-2932, 1988
12. Borresen AL, Andersen TI, Tretli S, et al: Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosom Cancer 2:339-340, 1990
13. Swift M, Reitnauer PJ, Morrell D, et al: Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316:1289-1294, 1987
14. Chen PC, Lavin MF, Kidson C, et al: Identification of ataxia telangiectasia heterozygotes, a cancer prone population. Nature 274:484-486, 1978
15. Natarajan AT, Meijers M, van Zeeland AA, et al: Attempts to detect ataxia telangiectasia (AT) heterozygotes by cytogenetical techniques. Cytogenet Cell Genet 33:145-151, 1982
16. Sanford KK, Parshad R, Price FM, et al: Enhanced chromatid damage in blood lymphocytes after G2 phase x irradiation, a marker of the ataxia-telangiectasia gene. J Natl Cancer Inst 82:1050-1054, 1990
17. Lavin MF, Le Poidevin P, Bates P: Enhanced levels of radiation-induced G2 phase delay in ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet 60:183-187, 1992
18. Pope JH, Home MK, Scott W: Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. Int J Cancer 3:857-866, 1968
19. Ehmann UK, Nagasawa H, Petersen DF, et al: Symptoms of X-ray damage to radiosensitive mouse leukemic cells: asynchronous populations. Radiat Res 60:453-472, 1974
20. d and s for sub-lines of murine leukaemic cells. Int J Radiat Biol 29:197-200, 1976
21. Scott D, Zampetti-Bosseler F: The relationship between cell killing, chromosome aberrations, spindle defects and mitotic delay in mouse lymphoma cells of differential sensitivity to X- rays. Int J Radiat Biol 37:33-47, 1980
22. Ford MD, Martin L, Lavin MF: The effects of ionizing radiation on cell cycle progession in ataxia telangiectasia. Mutat Res 125:115-122, 1984
23. Smith PJ, Anderson CO, Watson JV: Abnormal retention of x-irradiated ataxia-telangiectasia fibroblasts in G2 phase of the cell cycle: cellular RNA content, chromatin stability and the effects of 3-aminobenzamide. Int J Radiat Biol 47:701-712, 1985
24. Bates P, Lavin MF: Comparison of y-irradiation-induced accumulation of ataxia-telangiectasia and control cells in G2 phase. Mutat Res 218:165-170, 1989
25. Zampetti-Bosseler F, Scott D: Cell death, chromosome damage and mitotic delay in normal human, ataxia-telangiectasia and retinoblastoma fibroblasts after X-irradiation. Int J Radiat Biol 39:547-558, 1981
26. Beamish H, Lavin MF: Radiosensitivity in ataxia-telangiectasia: anomalies in radiation- induced cell cycle delay. Int J Radiat Biol 65:175-184, 1994
27. Kastan MB. Zhan Q, Deiry WS, et al: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597, 1992
28. Meyn MS, Strasfeld L, Allen C: Testing the role of p53 in the expression of genetic instability and apoptosis in ataxia-telangiectasia. Int J Radiat Biol. In press Swift M, Chase CL, Morrell D: Cancer predisposition of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet 46:21-27, 1990